Bin Yu

ORCID: 0000-0002-7207-643X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Epigenetics and DNA Methylation
  • Histone Deacetylase Inhibitors Research
  • Cancer therapeutics and mechanisms
  • Click Chemistry and Applications
  • Synthesis and biological activity
  • Ubiquitin and proteasome pathways
  • Chemical Synthesis and Analysis
  • Quinazolinone synthesis and applications
  • Protein Degradation and Inhibitors
  • Peptidase Inhibition and Analysis
  • Cancer-related gene regulation
  • Catalytic C–H Functionalization Methods
  • Synthesis and Biological Evaluation
  • Synthesis and Catalytic Reactions
  • Biochemical and Molecular Research
  • Drug Transport and Resistance Mechanisms
  • Pregnancy and preeclampsia studies
  • Synthetic Organic Chemistry Methods
  • Protein Tyrosine Phosphatases
  • Galectins and Cancer Biology
  • HIV/AIDS drug development and treatment
  • Lung Cancer Treatments and Mutations
  • Synthesis and Characterization of Heterocyclic Compounds
  • Estrogen and related hormone effects
  • Bioactive Compounds and Antitumor Agents

Zhengzhou University
2016-2025

Southwest University
2023-2025

Chongqing Medical University
2025

Fujian Medical University
2025

Taiyuan Central Hospital
2025

Jiangsu Cancer Hospital
2014-2024

Nanjing Medical University
2014-2024

Nanjing University
2018-2024

China Pharmaceutical University
2006-2024

Henan Normal University
2023-2024

Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at end 2019, thousands SARS-CoV-2 mutations have been increasingly observed. The virus epidemic has posed unprecedented challenges to global public health. As September 19, 2022, over 609 million confirmed cases and about 6.50 deaths worldwide reported World Health Organization. development novel antivirals capable treating infections a central focus current research. To cope with pneumonia (coronavirus...

10.1016/j.xinn.2022.100321 article EN cc-by-nc-nd The Innovation 2022-09-09

Abstract Nowadays, cell membrane‐targeted therapy, which owns high antitumor efficacy by avoiding barriers, has received great attention. Here, a self‐delivery theranostic chimeric peptide CMP‐PpIX is designed for simultaneously targeted photodynamic therapy (PDT) of tumor and real‐time therapeutic feedback. Self‐assembled nanoparticles can effectively accumulate in enhanced permeability retention effect without additional vector. And this low background fluorescence, due to its relatively...

10.1002/adhm.201901100 article EN Advanced Healthcare Materials 2019-11-25
Coming Soon ...